Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Urea is a keratolytic emollient used to treat hyperkeratotic lesions and moisturize the skin. A compound formed in the liver from ammonia produced by the deamination of amino acids.
- Mechanism
- Curator reviewed
Pharmacologically active on Dihydrofolate reductase
- Primary indication
- Urea is used topically for debridement and promotion of normal healing of hyperkeratotic surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or purulent debris or eschar.Curator reviewed · 22 structured indications
- Formula / weight
- CH4N2O · 60.0553 g/mol (avg)
- First approval
- Canada, 1997 · United States, 2017
- Also known as
- Carbamide · Carbonyldiamide
- Code names
- E-927A · INS-927A · INS NO.927A · NSC-34375
- Brand names
- Cem-urea
- Umecta
- Utopic
Resolves to
Structure
InChIKey
XSQUKJJJFZCRTK-UHFFFAOYSA-NSMILESNC(N)=OTransporters
What you can answer from here — as of September 28, 2026
5Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
2TransportersSubstrate / inhibitor direction, not just membership
Listed above
Which drugs share a target with Urea, and which of those have an active Phase 3 trial?